Real-time enrollment status for this acute leukemia clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 10:40 PM UTC
| NCT Number | NCT04099966 |
| Recruiting Status | Recruiting |
| Condition | Acute Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mitchell Cairo |
| Last Updated on CT.gov | August 8, 2025 (Aug 8, 2025) |
As of July 22, 2026: Clinical trial NCT04099966 is currently recruiting participants. This phase2 study for acute leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Mitchell Cairo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04099966 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04099966 was last updated Aug 8, 2025 (August 8, 2025). HelloStudys verifies this status automatically.